Skip to main content

Advertisement

Log in

The consumption of milk supplemented with probiotics decreases the occurrence of caries and the salivary concentration of hβD-3 in children

  • Original Article
  • Published:
Clinical Oral Investigations Aims and scope Submit manuscript

Abstract

Objectives

This study evaluated the effect of milk supplemented with Lactobacillus rhamnosus SP1 on the occurrence of caries and the salivary concentration of human β-defensin-3 (hβD-3) in preschool children with high caries risk.

Materials and methods

A sample of 42 children was randomly assigned to two groups; children in the intervention group were given 150 mL of milk supplemented with 107 CFU/mL of Lactobacillus rhamnosus SP1, while children in the control group were given standard milk, for 10 months. The occurrence of dental caries was assessed using the International Caries Detection and Assessment System (ICDAS), and the concentration of hβD-3 was measured in unstimulated saliva using an ELISA test at baseline and after the intervention.

Results

There was an increase in the number of teeth with carious lesions (dICDAS2-6 mft) in the control group, and this increase was statistically significant (p = 0.0489). The concentration of hβD-3 in saliva from the intervention group decreased from 597.91 to 126.29 pg/mL (p = 0.0061), unlike in the control group, where no change in hβD-3 salivary concentration was found.

Conclusions

These findings showed that regular intake of probiotic-supplemented milk in preschool children with high caries risk decreased the occurrence of caries and the salivary levels of hβD-3.

Clinical relevance

Our results suggest the need for developing and implementing probiotic supplementation, as adjuvants to the conventional treatments for caries and allow to considerate the salivary levels of hβD-3 as markers of oral tissue homeostasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Fejerskov O (2004) Changing paradigms in concepts on dental caries: consequences for oral health care. http://www.ncbi.nlm.nih.gov/pubmed/15153687. Accessed 28 July 2020

  2. Selwitz RH, Ismail AI, Pitts NB (2007) Dental caries. http://www.ncbi.nlm.nih.gov/pubmed/17208642. Accessed 28 July 2020

  3. Marsh PD (2010) Microbiology of dental plaque biofilms and their role in oral health and caries. http://www.ncbi.nlm.nih.gov/pubmed/20630188. Accessed 28 July 2020

  4. Takahashi N, Nyvad B (2011) The role of bacteria in the caries process: ecological perspectives. http://www.ncbi.nlm.nih.gov/pubmed/20924061. Accessed 28 July 2020

  5. Longbottom C, Ekstrand K, Zero D. Kambara M (2009) Novel preventive treatment options. http://www.ncbi.nlm.nih.gov/pubmed/19494683. Accessed 28 July 2020

  6. Meurman JH, Stamatova I (2007) Probiotics: contributions to oral health. http://www.ncbi.nlm.nih.gov/pubmed/17714346. Accessed 28 July 2020

  7. Hill CP, Yee J, Selsted ME, Eisenberg D (1991) Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. http://www.ncbi.nlm.nih.gov/pubmed/2006422. Accessed 28 July 2020

  8. ISAPP (2018) Minimum criteria for probiotics https://isappscience.org/minimum-criteria-probiotics/. Accessed 28 July 2020

  9. Chuang LC, Huang CS, Ou-Yang LW, Lin SY (2011) Probiotic Lactobacillus paracasei effect on cariogenic bacterial flora. http://www.ncbi.nlm.nih.gov/pubmed/20502929. Accessed 28 July 2020

  10. Petersson LG, Magnusson K, Hakestam U, Baigi A. Twetman S (2011) Reversal of primary root caries lesions after daily intake of milk supplemented with fluoride and probiotic lactobacilli in older adults. http://www.ncbi.nlm.nih.gov/pubmed/21563871. Accessed 28 July 2020

  11. Rodriguez G, Ruiz B, Faleiros S, Vistoso A, Marro ML, Sanchez J, Urzua I, Cabello R (2016) Probiotic compared with standard milk for high-caries children: a cluster randomized trial. http://www.ncbi.nlm.nih.gov/pubmed/26747421. Accessed 28 July 2020

  12. Singh RP, Damle SG. Chawla A (2011) Salivary mutans streptococci and lactobacilli modulations in young children on consumption of probiotic ice-cream containing Bifidobacterium lactis Bb12 and Lactobacillus acidophilus La5. http://www.ncbi.nlm.nih.gov/pubmed/21466258. Accessed 28 July 2020

  13. Taipale T, Pienihakkinen K, Alanen P, Jokela J, Soderling E (2013) Administration of Bifidobacterium animalis subsp. lactis BB-12 in early childhood: a post-trial effect on caries occurrence at four years of age. http://www.ncbi.nlm.nih.gov/pubmed/23571819. Accessed 28 July 2020

  14. Taipale T, Pienihakkinen K, Salminen S, Jokela J. Soderling E (2012) Bifidobacterium animalis subsp. lactis BB-12 administration in early childhood: a randomized clinical trial of effects on oral colonization by mutans streptococci and the probiotic. http://www.ncbi.nlm.nih.gov/pubmed/22327347. Accessed 28 July 2020

  15. Banna GL, Torino F, Marletta F, Santagati M, Salemi R, Cannarozzo E, Falzone L, Ferrau F, Libra M (2017) Lactobacillus rhamnosus GG: an overview to explore the rationale of its use in cancer. http://www.ncbi.nlm.nih.gov/pubmed/28919861. Accessed 28 July 2020

  16. Pace F, Pace M, Quartarone G (2015) Probiotics in digestive diseases: focus on Lactobacillus GG. http://www.ncbi.nlm.nih.gov/pubmed/26657927. Accessed 28 July 2020

  17. Vandenplas Y, Huys G, Daube G (2015) Probiotics: an update. http://www.ncbi.nlm.nih.gov/pubmed/25458874. Accessed 28 July 2020

  18. Matsubara VH, Bandara HM, Ishikawa KH, Mayer MP, Samaranayake LP (2016) The role of probiotic bacteria in managing periodontal disease: a systematic review. http://www.ncbi.nlm.nih.gov/pubmed/27224284. Accessed 28 July 2020

  19. Sivamaruthi BS, Kesika P, Chaiyasut C (2020) A review of the role of probiotic supplementation in dental caries. http://www.ncbi.nlm.nih.gov/pubmed/32307660. Accessed 28 July 2020

  20. Teughels W, Loozen G, Quirynen M (2011) Do probiotics offer opportunities to manipulate the periodontal oral microbiota? http://www.ncbi.nlm.nih.gov/pubmed/21323712. Accessed 28 July 2020

  21. Bonifait L, Chandad F, Grenier D (2009) Probiotics for oral health: myth or reality? http://www.ncbi.nlm.nih.gov/pubmed/19840501. Accessed 28 July 2020

  22. de Almeida PEV, Grégio AM, Machado MA, de Lima AA, Azevedo LR (2008) Saliva composition and functions: a comprehensive review. http://www.ncbi.nlm.nih.gov/pubmed/18335122. Accessed 28 July 2020

  23. Ganz T (2004) Defensins: antimicrobial peptides of vertebrates. http://www.ncbi.nlm.nih.gov/pubmed/15330253. Accessed 28 July 2020

  24. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. http://www.ncbi.nlm.nih.gov/pubmed/11807545. Accessed 28 July 2020

  25. Abiko Y, Saitoh M (2007) Salivary defensins and their importance in oral health and disease. http://www.ncbi.nlm.nih.gov/pubmed/17979749. Accessed 28 July 2020

  26. Duits LA, Ravensbergen B, Rademaker M, Hiemstra PS, Nibbering PH (2002) Expression of beta-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. http://www.ncbi.nlm.nih.gov/pubmed/12153515. Accessed 28 July 2020

  27. Harder J, Bartels J, Christophers E, Schroder JM (2001) Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. http://www.ncbi.nlm.nih.gov/pubmed/11085990. Accessed 28 July 2020

  28. Dhople V, Krukemeyer A, Ramamoorthy A (2006) The human beta-defensin-3, an antibacterial peptide with multiple biological functions. http://www.ncbi.nlm.nih.gov/pubmed/16978580. Accessed 28 July 2020

  29. Schlee M, Harder J, Koten B, Stange EF, Wehkamp J, Fellermann K (2008) Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2. http://www.ncbi.nlm.nih.gov/pubmed/18190603. Accessed 28 July 2020

  30. Moro-García MA, Alonso-Arias R, Baltadjieva M, Fernández Benítez C, Fernández Barrial MA, Díaz Ruisánchez E, Alonso Santos R, Alvarez Sánchez M, Saavedra Miján J, López-Larrea C (2013) Oral supplementation with Lactobacillus delbrueckii subsp. bulgaricus 8481 enhances systemic immunity in elderly subjects. http://www.ncbi.nlm.nih.gov/pubmed/22645023. Accessed 28 July 2020

  31. Schlee M, Wehkamp J, Altenhoefer A, Oelschlaeger TA, Stange EF, Fellermann K (2007) Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin. http://www.ncbi.nlm.nih.gov/pubmed/17283097. Accessed 28 July 2020

  32. Wehkamp J, Harder J, Wehkamp K, Wehkamp-von Meissner B, Schlee M, Enders C, Sonnenborn U, Nuding S, Bengmark S, Fellermann K, Schröder JM, Stange EF (2004) NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. http://www.ncbi.nlm.nih.gov/pubmed/15385474. Accessed 28 July 2020

  33. Kobayashi R, Kobayashi T, Sakai F, Hosoya T, Yamamoto M, Kurita-Ochiai T (2017) Oral administration of Lactobacillus gasseri SBT2055 is effective in preventing Porphyromonas gingivalis-accelerated periodontal disease. http://www.ncbi.nlm.nih.gov/pubmed/28373699. Accessed 28 July 2020

  34. Näse L, Hatakka K, Savilahti E, Saxelin M, Pönkä A, Poussa T, Korpela R, Meurman JH (2001) Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. http://www.ncbi.nlm.nih.gov/pubmed/11799281. Accessed 28 July 2020

  35. Keller MK, Hasslöf P, Stecksén-Blicks C, Twetman S (2011) Co-aggregation and growth inhibition of probiotic lactobacilli and clinical isolates of mutans streptococci: an in vitro study. http://www.ncbi.nlm.nih.gov/pubmed/21306197. Accessed 28 July 2020

  36. Keller MK, Larsen IN, Karlsson L, Twetman S (2014) Effect of tablets containing probiotic bacteria (Lactobacillus reuteri) on early caries lesions in adolescents: a pilot study. http://www.ncbi.nlm.nih.gov/pubmed/24889893. Accessed 28 July 2020

  37. Twetman L, Larsen U, Fiehn NE, Stecksén-Blicks C, Twetman S (2009) Coaggregation between probiotic bacteria and caries-associated strains: an in vitro study. http://www.ncbi.nlm.nih.gov/pubmed/19479452. Accessed 28 July 2020

  38. Angarita-Diaz MP, Forero-Escobar D, Ceron-Bastidas XA, Cisneros-Hidalgo CA, Davila-Narvaez F, Bedoya-Correa CM, Freitas SC, Cabrera-Arango CL, Melo-Colina R (2020) Effects of a functional food supplemented with probiotics on biological factors related to dental caries in children: a pilot study. http://www.ncbi.nlm.nih.gov/pubmed/31388942. Accessed 28 July 2020

  39. Cortes-Dorantes N, Ruiz-Rodriguez MS, Karakowsky-Kleiman L, Garrocho-Rangel JA, Sanchez-Vargas LO, Pozos-Guillen AJ (2015) Probiotics and their effect on oral bacteria count in children: a pilot study. http://www.ncbi.nlm.nih.gov/pubmed/25793955. Accessed 28 July 2020

  40. Hedberg M, Hasslöf P, Sjöström I, Twetman S, Stecksén-Blicks C (2008) Sugar fermentation in probiotic bacteria--an in vitro study. http://www.ncbi.nlm.nih.gov/pubmed/18954354. Accessed 28 July 2020

  41. Teughels W, Van Essche M, Sliepen I, Quirynen M (2008) Probiotics and oral healthcare. http://www.ncbi.nlm.nih.gov/pubmed/18715361. Accessed 28 July 2020

  42. Maldonado Galdeano C, Cazorla SI, Lemme Dumit JM, Velez E, Perdigon G (2019) Beneficial Effects of Probiotic Consumption on the Immune System. http://www.ncbi.nlm.nih.gov/pubmed/30673668. Accessed 28 July 2020

  43. Wattanarat O, Makeudom A, Sastraruji T, Piwat S, Tianviwat S, Teanpaisan R, Krisanaprakornkit S (2015) Enhancement of salivary human neutrophil peptide 1-3 levels by probiotic supplementation. http://www.ncbi.nlm.nih.gov/pubmed/25884192. Accessed 28 July 2020

  44. Joly S, Maze C, McCray PB Jr, Guthmiller JM (2004) Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. http://www.ncbi.nlm.nih.gov/pubmed/15004048. Accessed 28 July 2020

  45. Tao R, Jurevic RJ, Coulton KK, Tsutsui MT, Roberts MC, Kimball JR, Wells N, Berndt J, Dale BA (2005) Salivary antimicrobial peptide expression and dental caries experience in children. http://www.ncbi.nlm.nih.gov/pubmed/16127066. Accessed 28 July 2020

  46. Diamond G, Beckloff N, Weinberg A, Kisich KO (2009) The roles of antimicrobial peptides in innate host defense. http://www.ncbi.nlm.nih.gov/pubmed/19601838. Accessed 28 July 2020

  47. Diamond G, Ryan L (2011) Beta-defensins: what are they really doing in the oral cavity? http://www.ncbi.nlm.nih.gov/pubmed/21332602. Accessed 28 July 2020

  48. Zaura E, Twetman S (2019) Critical appraisal of oral pre- and probiotics for caries prevention and care. http://www.ncbi.nlm.nih.gov/pubmed/30947169. Accessed 28 July 2020

  49. Lima GQT, Brondani MA, Silva A, Carmo C, Silva RAD, Ribeiro CCC (2018) Serum levels of proinflammatory cytokines are high in early childhood caries. http://www.ncbi.nlm.nih.gov/pubmed/29895395. Accessed 28 July 2020

  50. Ribeiro CCC, Pacheco CJB, Costa EL, Ladeira LLC, Costa JF, da Silva RA, Carmo CDS (2018) Proinflammatory cytokines in early childhood caries: salivary analysis in the mother/children pair. http://www.ncbi.nlm.nih.gov/pubmed/29246654. Accessed 28 July 2020

  51. Ribeiro TR, Dria KJ, de Carvalho CB, Monteiro AJ, Fonteles MC, de Moraes Carvalho K, Fonteles CS (2013) Salivary peptide profile and its association with early childhood caries. http://www.ncbi.nlm.nih.gov/pubmed/22892037. Accessed 28 July 2020

  52. Sharma V, Gupta N, Srivastava N, Rana V, Chandna P, Yadav S, Sharma A (2017) Diagnostic potential of inflammatory biomarkers in early childhood caries - a case control study. http://www.ncbi.nlm.nih.gov/pubmed/28579141. Accessed 28 July 2020

  53. Lin TH, Lin CH, Pan TM (2018) The implication of probiotics in the prevention of dental caries. http://www.ncbi.nlm.nih.gov/pubmed/29192351. Accessed 28 July 2020

  54. Stecksén-Blicks C, Sjöström I, Twetman S (2009) Effect of long-term consumption of milk supplemented with probiotic lactobacilli and fluoride on dental caries and general health in preschool children: a cluster-randomized study. http://www.ncbi.nlm.nih.gov/pubmed/19690413. Accessed 28 July 2020

  55. Diamond G, Beckloff N, Ryan LK (2008) Host defense peptides in the oral cavity and the lung: similarities and differences. http://www.ncbi.nlm.nih.gov/pubmed/18809744. Accessed 28 July 2020

  56. Mileti E, Matteoli G, Iliev ID, Rescigno M (2009) Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. http://www.ncbi.nlm.nih.gov/pubmed/19756155. Accessed 28 July 2020

  57. Gamallat Y, Meyiah A, Kuugbee ED, Hago AM, Chiwala G, Awadasseid A, Bamba D, Zhang X, Shang X, Luo F, Xin Y (2016) Lactobacillus rhamnosus induced epithelial cell apoptosis, ameliorates inflammation and prevents colon cancer development in an animal model. http://www.ncbi.nlm.nih.gov/pubmed/27447122. Accessed 28 July 2020

  58. Khailova L, Baird CH, Rush AA, Barnes C, Wischmeyer PE (2017) Lactobacillus rhamnosus GG treatment improves intestinal permeability and modulates inflammatory response and homeostasis of spleen and colon in experimental model of Pseudomonas aeruginosa pneumonia. http://www.ncbi.nlm.nih.gov/pubmed/27745813. Accessed 28 July 2020

  59. Alipour B, Homayouni-Rad A, Vaghef-Mehrabany E, Sharif SK, Vaghef-Mehrabany L, Asghari-Jafarabadi M, Nakhjavani MR, Mohtadi-Nia J (2014) Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double-blind clinical trial. http://www.ncbi.nlm.nih.gov/pubmed/24673738. Accessed 28 July 2020

  60. Frech TM, Khanna D, Maranian P, Frech EJ, Sawitzke AD, Murtaugh MA (2011) Probiotics for the treatment of systemic sclerosis-associated gastrointestinal bloating/ distention. http://www.ncbi.nlm.nih.gov/pubmed/21586214. Accessed 28 July 2020

  61. Ganji-Arjenaki M, Rafieian-Kopaei M (2018) Probiotics are a good choice in remission of inflammatory bowel diseases: a meta analysis and systematic review. http://www.ncbi.nlm.nih.gov/pubmed/28294322. Accessed 28 July 2020

  62. Kouchaki E, Tamtaji OR, Salami M, Bahmani F, Daneshvar Kakhaki R, Akbari E, Tajabadi-Ebrahimi M, Jafari P, Asemi Z (2017) Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial. http://www.ncbi.nlm.nih.gov/pubmed/27669638. Accessed 28 July 2020

  63. Collado MC, Isolauri E, Salminen S, Sanz Y (2009) The impact of probiotic on gut health. http://www.ncbi.nlm.nih.gov/pubmed/19149514. Accessed 28 July 2020

  64. Plaza-Diaz J, Fernandez-Caballero JA, Chueca N, Garcia F, Gomez-Llorente C, Saez-Lara MJ, Fontana L, Gil A (2015) Pyrosequencing analysis reveals changes in intestinal microbiota of healthy adults who received a daily dose of immunomodulatory probiotic strains. http://www.ncbi.nlm.nih.gov/pubmed/26016655. Accessed 28 July 2020

  65. Plaza-Diaz J, Gomez-Llorente C, Campana-Martin L, Matencio E, Ortuno I, Martinez-Silla R, Gomez-Gallego C, Periago MJ, Ros G, Chenoll E, Genoves S, Casinos B, Silva A, Corella D, Portoles O, Romero F, Ramon D, Perez de la Cruz A, Gil A, Fontana L (2013) Safety and immunomodulatory effects of three probiotic strains isolated from the feces of breast-fed infants in healthy adults: SETOPROB study. http://www.ncbi.nlm.nih.gov/pubmed/24205115. Accessed 28 July 2020

  66. Menendez A, Ferreira RB, Finlay BB (2010) Defensins keep the peace too. http://www.ncbi.nlm.nih.gov/pubmed/20016512. Accessed 28 July 2020

  67. Milling S, Yrlid U, Cerovic V, MacPherson G (2010) Subsets of migrating intestinal dendritic cells. http://www.ncbi.nlm.nih.gov/pubmed/20193024. Accessed 28 July 2020

  68. Maisetta G, Batoni G, Esin S, Luperini F, Pardini M, Bottai D, Florio W, Giuca MR, Gabriele M, Campa M (2003) Activity of human beta-defensin 3 alone or combined with other antimicrobial agents against oral bacteria. http://www.ncbi.nlm.nih.gov/pubmed/14506056. Accessed 28 July 2020

  69. Ouhara K, Komatsuzawa H, Yamada S, Shiba H, Fujiwara T, Ohara M, Sayama K, Hashimoto K, Kurihara H, Sugai M (2005) Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, {beta}-defensins and LL37, produced by human epithelial cells. http://www.ncbi.nlm.nih.gov/pubmed/15886266. Accessed 28 July 2020

  70. Oppenheim FG, Xu T, McMillian FM, Levitz SM, Diamond RD, Offner GD, Troxler RF (1988) Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. http://www.ncbi.nlm.nih.gov/pubmed/3286634. Accessed 28 July 2020

  71. Durr UH, Sudheendra US, Ramamoorthy A (2006) LL-37, the only human member of the cathelicidin family of antimicrobial peptides. http://www.ncbi.nlm.nih.gov/pubmed/16716248. Accessed 28 July 2020

  72. Altman H, Steinberg D, Porat Y, Mor A, Fridman D, Friedman M, Bachrach G (2006) In vitro assessment of antimicrobial peptides as potential agents against several oral bacteria. http://www.ncbi.nlm.nih.gov/pubmed/16687459. Accessed 28 July 2020

  73. Siqueira WL, Margolis HC, Helmerhorst EJ, Mendes FM, Oppenheim FG (2010) Evidence of intact histatins in the in vivo acquired enamel pellicle. http://www.ncbi.nlm.nih.gov/pubmed/20351356. Accessed 28 July 2020

  74. Groenink J, Ruissen AL, Lowies D, van ‘t Hof W, Veerman EC, Nieuw Amerongen AV (2003) Degradation of antimicrobial histatin-variant peptides in Staphylococcus aureus and Streptococcus mutans. http://www.ncbi.nlm.nih.gov/pubmed/12939363. Accessed 28 July 2020

Download references

Funding

The work was supported by the Grant FIOUCH 17/011 from Dirección de Investigación, Facultad de Odontología, Universidad de Chile.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alejandro Escobar.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the ethics committee of the Faculty of Dentistry at the University of Chile (certificate no. 2011/14) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained in writing from the children’s parents or legal guardian.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sandoval, F., Faleiros, S., Cabello, R. et al. The consumption of milk supplemented with probiotics decreases the occurrence of caries and the salivary concentration of hβD-3 in children. Clin Oral Invest 25, 3823–3830 (2021). https://doi.org/10.1007/s00784-020-03712-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00784-020-03712-8

Keywords

Navigation